Related Experiment Videos
Control of beta-interferon expression in murine embryonal carcinoma F9 cells
1Department of Microbiology and Immunology, Albany Medical College, New York 12208.
Abstract:
Murine embryonal carcinoma F9 cells, a tissue culture model for early embryonic development, do not produce interferon (IFN) in response to poly(I-C), as determined by an antiviral assay. RNase protection analyses were used to examine total RNA extracted from the cells for the presence of beta-IFN RNA. Whereas F9 cells differentiated in vitro with retinoic acid produced a biologically active protein as well as beta-IFN RNA in response to poly(I-C), undifferentiated F9 cells produced no detectable beta-IFN RNA even in the presence of cycloheximide, an IFN-superinducing agent. These results show that undifferentiated embryonal carcinoma cells do not accumulate beta-IFN RNA in response to an IFN-inducing agent, suggesting a transcriptional regulatory mechanism. However, this control mechanism is altered upon differentiation, since the gene can be transcriptionally activated in retinoic acid-differentiated cells.
Insights
Undifferentiated F9 embryonal carcinoma cells do not produce beta-interferon (IFN) RNA. Differentiation with retinoic acid enables beta-IFN RNA production in response to poly(I-C), indicating altered transcriptional regulation.
Area of Science:
- Developmental Biology
- Immunology
- Molecular Biology
Background:
- Murine embryonal carcinoma F9 cells serve as a model for early embryonic development.
- Interferon (IFN) production is a key immune response.
- The regulation of IFN gene expression is crucial for cellular defense and development.
Purpose of the Study:
- To investigate the production of beta-interferon (IFN) RNA in undifferentiated and retinoic acid-differentiated F9 cells.
- To determine the effect of poly(I-C) and cycloheximide on beta-IFN RNA accumulation.
- To elucidate the transcriptional regulatory mechanisms governing beta-IFN gene expression during cellular differentiation.
Main Methods:
- Antiviral assays to detect biologically active IFN.
- RNase protection analyses to quantify beta-IFN RNA levels.
- In vitro differentiation of F9 cells using retinoic acid.
Main Results:
- Undifferentiated F9 cells did not produce detectable beta-IFN RNA in response to poly(I-C), even with cycloheximide.
- Retinoic acid-differentiated F9 cells produced beta-IFN RNA and biologically active IFN upon stimulation with poly(I-C).
- These findings suggest a block in beta-IFN RNA accumulation at the transcriptional level in undifferentiated cells.
Conclusions:
- Undifferentiated embryonal carcinoma cells possess a regulatory mechanism that prevents beta-IFN RNA accumulation in response to IFN-inducing agents.
- Cellular differentiation, induced by retinoic acid, alters this regulatory mechanism, allowing for transcriptional activation of the beta-IFN gene.
- This study highlights the dynamic regulation of interferon gene expression during early embryonic development and differentiation.